Allogeneic Bone Marrow Transplantation for the Treatment of Genetic Disorders of Erythropoiesis

NCT00578435 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Genetic Disorders
Sickle Cell Anemia

Interventions

PROCEDURE: Busulfan, Cyclophosphamide, BMD

Sponsor

Memorial Sloan Kettering Cancer Center